Travere Therapeutics (TVTX) Other Non Operating Income (2013 - 2026)

Travere Therapeutics (TVTX) has 14 years of Other Non Operating Income data on file, last reported at -$91000.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 116.58% year-over-year to -$91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$860000.0 (down 4958.82% YoY) and the FY2025 annual result came in at -$219000.0, up 33.23% from the prior year.
• Other Non Operating Income improved to -$91000.0 in Q1 2026, from -$730000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.4 million in Q4 2024 to a low of -$3.5 million in Q2 2024.
• A 5-year average of -$54933.3 and a median of $87000.0 in 2023 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 1464.29% in 2024, down 1638.81% in 2024.
• Tracing TVTX's Other Non Operating Income over 5 years: stood at -$586000.0 in 2022, then jumped by 126.28% to $154000.0 in 2023, then surged by 1464.29% to $2.4 million in 2024, then slumped by 130.3% to -$730000.0 in 2025, then soared by 87.53% to -$91000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$91000.0 (Q1 2026), -$730000.0 (Q4 2025), and $487000.0 (Q3 2025), per Business Quant data.